| Bioactivity | L-(+)-Arabinose selectively inhibits intestinal sucrase activity in a noncompetitive manner and suppresses the plasma glucose increase due to sucrose ingestion. | ||||||||||||
| Invitro | L-(+)-Arabinose selectively inhibits intestinal sucrase activity in a noncompetitive manner and suppresses the plasma glucose increase due to sucrose ingestion[1]. L-(+)-Arabinose is found to be associated with ribose-5-phosphate isomerase deficiency, which is an inborn error of metabolism[2]. | ||||||||||||
| Name | L-(+)-Arabinose | ||||||||||||
| CAS | 5328-37-0 | ||||||||||||
| Formula | C5H10O5 | ||||||||||||
| Molar Mass | 150.13 | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
L-(+)-Arabinose
CAS: 5328-37-0 F: C5H10O5 W: 150.13
L-(+)-Arabinose selectively inhibits intestinal sucrase activity in a noncompetitive manner and suppresses the plasma gl
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.